| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Sa | Five Star Bank: Five Star Bancorp Declares First Quarter Cash Dividend | ||
| Sa | Terra Innovatum Global N.V.: Terra Innovatum Provides Update on Annual Report Filing Process | ||
| Fr | Itafos Announces Release Date for Q1 2026 Results and Business Update Webcast | ||
| Fr | Rocket Doctor AI Inc.: Rocket Doctor Amends 45 Degree Agreement | ||
| Fr | Iovance Biotherapeutics, Inc.: Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) | ||
| Fr | Hampton Financial Corporation: Hampton Completes Issuance of Shares for Debt | ||
| Fr | LGI Homes, Inc.: LGI Homes Expands in the Salt Lake City Market with Grand Opening of Desert Edge | ||
| Fr | Black Iron Inc.: Black Iron Announces Closing of LIFE Offering | ||
| Fr | Boundless Bio, Inc.: Boundless Bio Presents Preclinical Breast Cancer Data from its Oral Kinesin Degrader Program at 2026 AACR Annual Meeting | ||
| Fr | Sysco Corporation: Sysco Declares Increase to Quarterly Dividend Payment | ||
| Fr | Tree Island Steel Ltd.: Tree Island Steel Provides Update on Annual General Meeting of Shareholders | ||
| Fr | Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ||
| Fr | Zacatecas Silver Corp.: Zacatecas Silver Announces Investor Relations Engagement | ||
| Fr | Sonoco Products Company: Sonoco To Report First Quarter 2026 Results | ||
| Fr | ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules | ||
| Fr | QuasarEdge Acquisition Corporation Announces Exercise of Over-Allotment Option | ||
| Fr | 4D Molecular Therapeutics, Inc.: 4DMT Announces New Employment Inducement Grants | ||
| Fr | SEALSQ Announces Agenda of its 2026 Annual General Meeting of Shareholders | ||
| Fr | ORIC Pharmaceuticals Presents Preclinical Data to Support the Potential of Rinzimetostat Across Prostate Cancer and in Emerging Resistance Settings at the 2026 American Association for Cancer Research (AACR) Annual Meeting | ||
| Fr | Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026 | ||
| Fr | Talen Energy Corporation: Talen Energy Announces Pricing of Senior Notes | ||
| Fr | CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ||
| Fr | Xilio Therapeutics, Inc.: Xilio Therapeutics Announces New Preclinical Data at AACR Annual Meeting for XTX601, a Masked T Cell Engager Targeting CLDN18.2 | ||
| Fr | Adagene Inc.: Adagene Presents Two Posters at AACR 2026 with New Data Highlighting Muzastotug's Potential as a Backbone Combination Therapy for Multiple Tumor Types | ||
| Fr | Cardiff Oncology, Inc.: Cardiff Oncology Presents Preclinical Data on its PLK1 Inhibitor Onvansertib in Combination with a HER2-Targeted ADC at the 2026 AACR Annual Meeting |